LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.7700
-0.0101 (-1.29%)
At close: Oct 17, 2025
LakeShore Biopharma Revenue
In the fiscal year ending March 31, 2025, LakeShore Biopharma had annual revenue of 614.96 million CNY with 7.24% growth. LakeShore Biopharma had revenue of 135.35 million in the quarter ending March 31, 2024, with 27.67% growth.
Revenue
614.96M CNY
Revenue Growth
-6.54%
P/S Ratio
0.37
Revenue / Employee
1.07M CNY
Employees
573
Market Cap
31.73M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 614.96M | 41.54M | 7.24% |
Mar 31, 2024 | 573.42M | -113.78M | -16.56% |
Mar 31, 2023 | 687.20M | 184.25M | 36.63% |
Mar 31, 2022 | 502.95M | 245.93M | 95.69% |
Mar 31, 2021 | 257.02M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Federal National Mortgage Association | 28.89B |
Federal Home Loan Mortgage | 22.97B |
First National of Nebraska | 1.89B |
Central Bancompany | 914.42M |
Procaps Group | 423.75M |
Wilson Bank Holding Company | 197.85M |
Wilhelmina International | 18.03M |
IPE Universal | 17.33M |
LakeShore Biopharma News
- 27 days ago - LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting - PRNewsWire
- 5 weeks ago - LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq - PRNewsWire
- 5 weeks ago - LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee - PRNewsWire
- 7 weeks ago - LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee - PRNewsWire
- 2 months ago - LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company - PRNewsWire
- 2 months ago - LakeShore Biopharma Announces Fiscal Year 2025 Financial Results - PRNewsWire
- 3 months ago - LakeShore Biopharma Announces US$15 Million Private Placement Financing - PRNewsWire
- 6 months ago - LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell) - PRNewsWire